Genentech chooses Google for Outlook

Genentech says it sees Google as a strategic IT platform, reports ChannelWeb. The big biopharma moved its 15,000 employees to Google Apps last year, despite seeing user preference for Outlook as hurdle. Genentech credits Google's MAPI-based synchronizer for overcoming earlier performance issues compared with Microsoft Exchange. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.